Properties of the weighted log-rank test under delayed effects assumption in the design of confirmatory studies with delayed effects

06/29/2018
by   Jose L Jimenez, et al.
0

Proportional hazards are a common assumption when designing confirmatory clinical trials in oncology. This assumption not only affects the analysis part but also the sample size calculation. The presence of delayed effects causes a change in the hazard ratio while the trial is ongoing since at the beginning we do not observe any difference between treatment arms and after some unknown time point, the differences between treatment arms will start to appear. Hence, the proportional hazards assumption no longer holds and both sample size calculation and analysis methods to be used should be reconsidered. The weighted log-rank test allows a weighting for early, middle and late differences through the Fleming and Harrington class of weights, and is proven to be more efficient when the proportional hazards assumption does not hold. The Fleming and Harrington class of weights, along with the estimated delay, can be incorporated into the sample size calculation in order to maintain the desired power once the treatment arm differences start to appear. In this article, we explore the impact of delayed effects in group sequential and adaptive group sequential designs, and make an empirical evaluation in terms of power and type-I error rate of the of the weighted log-rank in a simulated scenario. We also give some practical recommendations regarding which methodology should be used in the presence of delayed effects depending on certain characteristics of the trial.

READ FULL TEXT

page 1

page 2

page 3

page 4

research
08/28/2019

Quantifying treatment differences in confirmatory trials with delayed effects

Dealing with non-proportional hazards is increasingly common nowadays wh...
research
02/01/2019

Bayesian optimality of testing procedures for survival data

Most statistical tests for treatment effects used in randomized clinical...
research
03/18/2021

A unified framework for weighted parametric group sequential design (WPGSD)

Group sequential design (GSD) is widely used in clinical trials in which...
research
02/10/2021

Designing group sequential clinical trials when a delayed effect is anticipated: A practical guidance

A common feature of many recent trials evaluating the effects of immunot...
research
08/20/2019

Robust Design and Analysis of Clinical Trials With Non-proportional Hazards: A Straw Man Guidance from a Cross-pharma Working Group

Loss of power and clear description of treatment differences are key iss...
research
10/05/2020

The use of restricted mean time lost under competing risks data

Background: Under competing risks, the commonly used sub-distribution ha...
research
11/13/2019

A Simulation-free Group Sequential Design with Max-combo Tests in the Presence of Non-proportional Hazards

Non-proportional hazards (NPH) have been observed recently in many immun...

Please sign up or login with your details

Forgot password? Click here to reset